BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18825403)

  • 1. Molecular imaging with nanoparticles: giant roles for dwarf actors.
    Debbage P; Jaschke W
    Histochem Cell Biol; 2008 Nov; 130(5):845-75. PubMed ID: 18825403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
    Cheon J; Lee JH
    Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents.
    Arami H; Khandhar AP; Tomitaka A; Yu E; Goodwill PW; Conolly SM; Krishnan KM
    Biomaterials; 2015 Jun; 52():251-61. PubMed ID: 25818431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use.
    Skotland T
    Contrast Media Mol Imaging; 2012; 7(1):1-6. PubMed ID: 22344874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical Imaging: Principles, Technologies, Clinical Aspects, Contrast Agents, Limitations and Future Trends in Nanomedicines.
    Wallyn J; Anton N; Akram S; Vandamme TF
    Pharm Res; 2019 Apr; 36(6):78. PubMed ID: 30945009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography.
    Zhang Q; Iwakuma N; Sharma P; Moudgil BM; Wu C; McNeill J; Jiang H; Grobmyer SR
    Nanotechnology; 2009 Sep; 20(39):395102. PubMed ID: 19726840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities.
    Park JI; Jagadeesan D; Williams R; Oakden W; Chung S; Stanisz GJ; Kumacheva E
    ACS Nano; 2010 Nov; 4(11):6579-86. PubMed ID: 20968309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifunctional Polymeric Nanocomposites Incorporated with Fe₃O₄/Iodine-Containing Rare Earth Complex for Computed X-ray Tomography, Magnetic Resonance, and Optical Imaging.
    Wang X; Tu M; Yan K; Li P; Pang L; Gong Y; Li Q; Liu R; Xu Z; Xu H; Chu PK
    ACS Appl Mater Interfaces; 2015 Nov; 7(44):24523-32. PubMed ID: 26484385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of FeBi nanoparticles for imaging applications.
    Branca M; Pelletier F; Cottin B; Ciuculescu D; Lin CC; Serra R; Mattei JG; Casanove MJ; Tan R; Respaud M; Amiens C
    Faraday Discuss; 2014; 175():97-111. PubMed ID: 25271897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on the role of lipid-based nanoparticles in medical diagnosis and imaging.
    Mirahadi M; Ghanbarzadeh S; Ghorbani M; Gholizadeh A; Hamishehkar H
    Ther Deliv; 2018 Aug; 9(8):557-569. PubMed ID: 30071803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives.
    Hahn MA; Singh AK; Sharma P; Brown SC; Moudgil BM
    Anal Bioanal Chem; 2011 Jan; 399(1):3-27. PubMed ID: 20924568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of inorganic nanomaterials in biomedical imaging.
    Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
    Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliphatic polyesters for medical imaging and theranostic applications.
    Nottelet B; Darcos V; Coudane J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):350-70. PubMed ID: 26614557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon nanotubes for biomedical imaging: the recent advances.
    Gong H; Peng R; Liu Z
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1951-63. PubMed ID: 24184130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics.
    Godin B; Tasciotti E; Liu X; Serda RE; Ferrari M
    Acc Chem Res; 2011 Oct; 44(10):979-89. PubMed ID: 21902173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.